Axsome Therapeutics (AXSM) Reports Q4 Loss Per Share of $0.12
Axsome Therapeutics (NASDAQ: AXSM) reported Q4 EPS of ($0.12), versus ($0.14) reported last year.
For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.
Axsome Therapeutics (NASDAQ: AXSM) reported Q4 EPS of ($0.12), versus ($0.14) reported last year.
For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.